Today’s Irish Daily Mail (February 21st 2011) has an article on Alpha-1 Antitrypsin Deficiency (Alpha-1) written by their health editor Petrina Vousden (page 12).
In the article Alpha-1 patient Orla Keane explains how she was first diagnosed and how she is living with the condition. Professor Gerry McElvaney chairman of the Alpha One Foundation also contributed to the article. He explained the importance of testing patients with lung and liver disease for Alpha-1 as “Ninety five per cent of people with Alpha-1 are totally unaware of it”. The national targeted detection programme for Alpha-1 Antitrypsin Deficiency is a screening programme funded by the Department of Health, and has tested over 5000 Irish individuals, a quarter of which have some evidence of the condition. The key is early diagnosis of the condition, which can help prevent or postpone the development of lung disease and leads to more effective management.
Info Centre
WhatisAlpha-1Antitrypsin?
Alpha-1 antitrypsin is a vital protein produced by the liver to protect the lungs. It provides protection from the harmful effects of infections and inhaled irritants, particularly tobacco smoke. It can be easily measured by a simple blood test.
WhatisAlpha-1AntitrypsinDeficiency?
Alpha-1 antitrypsin deficiency (Alpha-1) is a genetic condition which, after cystic fibrosis, is the commonest genetic disorder in Ireland. It severely affects more than 15,000 people, with another 250,000 carriers also at risk of lung and liver disease on the island of Ireland. It is a proven genetic risk factor for chronic obstructive pulmonary disease (COPD).
HowDoIGetTested?
The Alpha-1 Foundation Ireland provides free testing for Alpha-1 as part of a national screening programme which is funded by the HSE. It is a simple blood test. For more details ring 01-8093871 or email alpha1@rcsi.ie
Irish Daily Mail interview with Alpha-1 patient
Today’s Irish Daily Mail (February 21st 2011) has an article on Alpha-1 Antitrypsin Deficiency (Alpha-1) written by their health editor Petrina Vousden (page 12).
In the article Alpha-1 patient Orla Keane explains how she was first diagnosed and how she is living with the condition. Professor Gerry McElvaney chairman of the Alpha One Foundation also contributed to the article. He explained the importance of testing patients with lung and liver disease for Alpha-1 as “Ninety five per cent of people with Alpha-1 are totally unaware of it”. The national targeted detection programme for Alpha-1 Antitrypsin Deficiency is a screening programme funded by the Department of Health, and has tested over 5000 Irish individuals, a quarter of which have some evidence of the condition. The key is early diagnosis of the condition, which can help prevent or postpone the development of lung disease and leads to more effective management.
Info Centre
What is Alpha-1 Antitrypsin?
Alpha-1 antitrypsin is a vital protein produced by the liver to protect the lungs. It provides protection from the harmful effects of infections and inhaled irritants, particularly tobacco smoke. It can be easily measured by a simple blood test.
What is Alpha-1 Antitrypsin Deficiency?
Alpha-1 antitrypsin deficiency (Alpha-1) is a genetic condition which, after cystic fibrosis, is the commonest genetic disorder in Ireland. It severely affects more than 15,000 people, with another 250,000 carriers also at risk of lung and liver disease on the island of Ireland. It is a proven genetic risk factor for chronic obstructive pulmonary disease (COPD).
How Do I Get Tested?
The Alpha-1 Foundation Ireland provides free testing for Alpha-1 as part of a national screening programme which is funded by the HSE. It is a simple blood test. For more details ring 01-8093871 or email alpha1@rcsi.ie